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Background. A higher frequency of clinical events has been observed in patients under-
going pharmacological vs exercise myocardial perfusion single-photon emission computed
tomography (SPECT). While this difference is attributed to greater age and co-morbidities, it is
not known whether these tests also differ in prognostic ability among patients with similar
clinical proﬁles.
Methods and Results. We assessed all-cause mortality rates in 6,069 patients, followed for
10.2 ± 1.7 years after undergoing exercise or adenosine SPECT. We employed propensity
analysis to match exercise and adenosine subgroups by age, gender, symptoms, and coronary
risk factors. Within our propensity-matched cohorts, adenosine patients had an annualized
mortality rate event rates that was more than twice that of exercise patients (3.9% vs 1.6%,
P < .0001). Differences in mortality persisted among age groups, including those <55 years old.
In the exercise cohort, mortality was inversely related to exercise duration, with comparable
mortality noted for patients exercising <3 min and those undergoing adenosine testing.
Conclusions. Among patients with normal stress SPECT tests, those undergoing adenosine
testing manifest a mortality rate that is substantially higher than that observed among ade-
quately exercising patients, but comparable to that observed among very poorly exercising
patients. This elevated risk underscores an important challenge for managing patients under-
going pharmacological stress testing. (J Nucl Cardiol 2010;17:999–1008.)
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INTRODUCTION
Stress testing using single-photon emission com-
puted tomography (SPECT) for myocardial perfusion
imaging is currently widely used to guide many com-
mon medical management decisions, such as the need
for cardiac catheterization among diagnostic patients or
the need for myocardial revascularization among
patients with known coronary artery disease (CAD).
1 A
basis of such use is the understanding that a normal
stress SPECT study reliably identiﬁes low-risk patients
who can be successfully managed without the need
for aggressive interventions. With respect to exercise
SPECT, repeated investigation has conﬁrmed that nor-
mal SPECT studies deﬁne patients with\1% annualized
event rate for cardiac events.
1,2 It is widely assumed that
normal pharmacological SPECT studies also identify
low-risk patients, yet meta-analysis of this issue
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999indicates that normal pharmacological stress studies are
associated with somewhat higher event rates compared
to those reported for exercise SPECT.
3 This difference
has been attributed to the greater age and co-existing
morbidities that are usually present among patients who
require pharmacological stress testing in lieu of exercise.
However, is it possible that pharmacological stress
simply limited in its ability to identify patients who are
at low risk for cardiac events? Given the now large
percent of SPECT studies currently performed with
pharmacological stress, such a ﬁnding could be of great
management signiﬁcance. To examine this issue, we
applied propensity analysis to compare long-term mor-
tality among age and risk proﬁle-matched patients
manifesting a normal scintigraphic study during exercise
vs adenosine myocardial perfusion SPECT.
METHODS
Study Design
We identiﬁed 8,504 consecutive patients undergoing
physician-ordered stress/rest dual SPECT at Cedars Sinai
Medical Center (CSMC) who were free of known CAD (no
prior myocardial infarction, bypass surgery, or percutaneous
coronary intervention) or of a prior clinical diagnosis of car-
diomyopathy (i.e., known LV dysfunction due to ischemic or
non-ischemic causes). We excluded 2,435 patients who man-
ifested evidence of myocardial ischemia on SPECT imaging or
who required testing using dobutamine stress. The remaining
6,069 patients with normal myocardial perfusion SPECT
studies constituted our patient population. They had a mean
age of 62 ± 13 years and 3,122 (51%) male patients. All
patients were prospectively enrolled in a research database at
the time of testing and were followed for the occurrence of
adverse clinical events. The study was approved by the CSMC
Institutional Review Board.
Historical Variables
All patients completed a questionnaire to elicit informa-
tion regarding personal demographics, chest pain symptoms,
cardiac risk factors, and medication use. From the answer to
three questions regarding chest pain (location, precipitants, and
relief with rest or nitroglycerin), we identiﬁed four chest pain
categories (asymptomatic, non-anginal chest pain, atypical,
and typical angina). We also identiﬁed which patients com-
plained of dyspnea only.
4
Imaging and Stress Protocol
Exercise testing was performed using the Bruce protocol
exercise. For exercising patients in whom difﬁculty with exer-
cise was anticipated, we employed a modiﬁed Bruce protocol
with exercise beginning at 1.7 mph at zero incline (1 min) and
then increased to a 5% incline (1 min) followed by the usual
Bruce protocol (beginning at 1.7 mph at a 10% incline). Heart
rate, systolic and diastolic blood pressure measurements, and
ECG tracings were obtained at rest and monitored during and
after stress testing. The decision to perform exercise or adeno-
sine testing was primarily based on the request of the referring
physicians, but the ﬁnal choice of protocol was modiﬁed as
deemed appropriate by our supervising personnel. Patients who
began exercise but who could not achieve 85% of their maximal
predicted heart rate were generally converted into adenosine
studies. The most common reasons for performing adenosine
testing included patient inability to exercise due to co-morbid
medical conditions (e.g., musculoskeletal problems or impaired
gait)orhistoryofpoorexerciseconditioning;failuretowithhold
beta-blocking medication; high resting blood pressure; and the
presence of left bundle block or paced rhythm.
Patients were injected intravenously with thallium-201
(Tl-201) (3.0-4.5 mCi) at rest and Tc-99m sestamibi (25-
40 mCi) at stress, using weight-adjusted doses. Rest Tl-201
SPECT was initiated 10 min after radionuclide injection and
afterward, symptom-limited treadmill exercise was performed
in 4,557 (75%) patients and adenosine infusion testing was
performed in 1,512 (25%) patients.
Exercising patients were stopped before reaching
exhaustion only for severe angina, sustained ventricular
tachycardia, hemodynamically signiﬁcant supraventricular
dysrhythmias, or exertional hypotension. Radioisotope was
injected at near maximal exercise. When tolerated, exercise
was continued at maximal workload for an additional minute
and then at a reduced workload for an additional 2 min.
Tc-99m sestamibi SPECT imaging was begun 15-30 min after
exercise radiopharmaceutical injection.
5
For adenosine testing, Tc-99m sestamibi was injected at
the end of the third minute or at the end of the second minute
of 5- or 6-min adenosine infusions, respectively (140 mcg/kg/
min for both).
6 Our ‘‘adeno walk’’ protocol for concomitant
low-level treadmill exercise was only performed in 146 (10%)
of our adenosine patients because this protocol was not insti-
tuted until 1995-1996. In the patients not undergoing the
adeno-walk, SPECT imaging was delayed for approximately
60 min after injection during the adenosine infusion. Patients
undergoing adenosine testing were instructed not to consume
caffeine containing products for 24 h prior to testing, and they
were routinely queried as to their adherence to this instruction
prior to testing by our supervisory personnel. For patients
ingesting caffeine containing products within 24 h of stress
testing, the SPECT study was either re-scheduled or converted
into a dobutamine stress test. Both exercise and adenosine
patients were instructed to withhold beta-blocking medication
for 48 h and calcium blockers for 24 h prior to testing, but
among exercise patients, 8.3% were tested under the inﬂuence
of calcium blockers and 6% under the inﬂuence of beta-
blockers, and among the adenosine patients, 12% and 11%
were tested under the inﬂuence of calcium and beta blockers,
respectively (P\.001 for both vs exercise, respectively).
SPECT Acquisition Protocol
SPECT studies were performed on multidetector scintil-
lation cameras using an elliptical 180 acquisition for 60-64
1000 Rozanski et al Journal of Nuclear Cardiology
Adenosine vs exercise SPECT November/December 2010projections at 20 s per projection.
5 For Tl-201, two energy
windows were used, including a 30% window centered on the
68- to 80-keV peak and a 10% window centered on the
167 keV peak. For Tc-99m sestamibi SPECT, a 15% window
centered on the 140-keV peak was used, and images were
obtained in both supine and prone positions.
7 Images were
acquired using a 64 9 64 image matrix and were subject to
quality control measures as previously described.
SPECT Interpretation
Semi-quantitative visual interpretation was performed
using 20 segments for each image set. Segments were scored
by consensus of two experienced observers. This interpretation
was performed ﬁrst blinded to the clinical information and then
could be minimally modiﬁed based on the clinical data avail-
able as previously described,
8 using a ﬁve-point score
(0 = normal, 1 = equivocal, 2 = moderate, 3 = severe
reduction of radioisotope uptake, and 4 = absence of detect-
able tracer uptake in a segment).
5 Summed stress scores (SSS)
and summed rest scores were obtained by adding the scores of
the 20 segments of the respective images. An SSS C 4 was
used to deﬁne the presence of an abnormal study. Scintigraphic
left ventricular size was subjectively categorized as either no,
equivocal, or deﬁnite enlargement. The SPECT studies were
also assessed visually for the presence of transient ischemic
dilation (TID) of the left ventricle on the ungated SPECT
images (scored as yes, no, equivocal, and only yes being
considered present), with support of the visual interpretation
coming from use of a previously described commercially
available automated program (QPS, Cedars-Sinai, Lost Ange-
les, CA, USA).
9
Follow-up
We ascertained overall all-cause mortality in our patient
population, based on the analysis of the Social Security Death
Index (SSDI). Average follow-up time was 10.2 ± 1.7 years.
We also evaluated the results of available shorter-term follow-
up (mean of 2.6 ± 2.1 years) to assess the frequency of hard
cardiac events, which included cardiac death and non-fatal
myocardial infarction, as evidenced by the appropriate combi-
nation of patient signs, symptoms, ECG changes, and enzyme
elevations; during this time, 150 patients (2.5%) were lost to
cardiac follow-up. The conﬁrmation of cardiac death was
ascertained through examination of the records obtained
through the blinded examination of our hospital-based patient
information system (WebVS) and death certiﬁcates for all who
died in Los Angeles County. Information regarding the per-
formance and timing of revascularization procedures was also
obtained, but was not used to censor patients with respect to all-
cause mortality or cardiac death since most studies employing
the SSDI would not normally have access to such data.
Statistical Analyses
All data were analyzed using Stata software version 11
[StataCorp. 2005. Stata Statistical Software: Release 11.
College Station, TX: StataCorp LP]. Continuous variables
were compared using the Wilcoxon rank-sum test because
assumptions of the t-test were not met. Categorical variables
were compared using Pearson v
2 test or Fisher’s Exact test if
cell counts of\6 were present. The v
2 test for trend was used
when testing for trend. Survival curves were compared using
the log-rank test or a test for trend across ordered groups, and
Kaplan–Meier curves were graphed. Event rates were calcu-
lated by dividing the number of events by person-years, and
compared across groups using the log-rank test. Twenty-four
patients who underwent early revascularization procedures
(bypass surgery or percutaneous coronary intervention) within
the ﬁrst 60 days after stress testing were censored for assessing
the shorter-term cardiovascular outcomes. However, we did
not censor patients undergoing early myocardial revasculari-
zation for the assessment of long-term mortality. Propensity
matching was done using STATA’s pscore
10 and psmatch
commands. Propensity scores were obtained
10,11 to match non-
ischemic exercise to adenosine patients, based on age, gender,
chest pain symptoms, and coronary disease risk factors. In
order to create propensity-matched groups which had a low
incidence of co-existing cardiac morbidities, we excluded
patients with paced rhythm, left bundle branch block, atrial
ﬁbrillation, taking digoxin, manifesting TID, and those who
had left ventricular enlargement or shortness of breath from
this propensity analysis. The propensity scores were derived
from the predicted probabilities of being in the adenosine vs the
exercise group in a logistic regression model where the
covariates were the above-mentioned matching variables (see
Appendix). The balancing property of the propensity score was
tested by stratifying into blocks and conﬁrming that the mean
propensity score was not signiﬁcantly different in each block
for adenosine and exercise patients.
10 The matching was done
using the single nearest-neighbor without caliper matching,
with no replacement.
11 In the propensity-matched patients, we
compared continuous variables using the Wilcoxon signed-rank
test, and we compared categorical variables using McNemar’s
test or McNemar’s Exact test for small cell counts\6.
RESULTS
Table 1 compares the clinical characteristics of the
exercise and adenosine SPECT groups. The adenosine
patients were older, had fewer males, greater BMI, a
greater mean pre-test likelihood of CAD, and they con-
tained more patients with chest pain symptom. The
adenosine patients also had a greater frequency of dia-
betes and hypertension, lower frequency of smokers,
higher resting mean heart rate and systolic blood pres-
sure, and more frequent LBBB, LVH, and atrial
ﬁbrillation, and less frequent left ventricular enlarge-
ment. During a mean follow-up of 10.2 ± 1.7 years
(range 7.5-14 years), 978 patients (16.1%) died, includ-
ing 466 (10%) of the exercise patients, and 512 (34%) of
the adenosine patients. The annualized mortality event
rate was markedly higher in the adenosine patients
compared to the exercising patients (4.3% [95% CI:
Journal of Nuclear Cardiology Rozanski et al 1001
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This difference in mortality rates was present both for
adenosine vs exercise patients tested without inﬂuence of
beta-blocking medications (4.5% vs 1.0%, P\.0001)
and those tested under the inﬂuence of beta-blocking
medication (3.1% vs 1.2%, P\.0001). Likewise the
annual mortality rate was 4.2% vs 1.0% (P\.0001) and
5.3% vs 1.5% (P\.0001) for adenosine vs exercise
patients, for those not under the inﬂuence and those
under the inﬂuence of calcium channel blockers,
respectively.
The presence of TID was noted among 7 (0.2%) of
the exercise patients and 7 (0.5%) of the adenosine
patients (P = .03), and in both groups, the annualized
mortality rate (presented with conﬁdence intervals) was
higher for those with TID than those without: 4.8%
(1.5%-14.9%) vs 1.0% (1.0%-1.1%), P = .003, for the
exercise patients, and 7.9% (3.0%-21.2%) vs 4.3%
(3.9%-4.7%), P = .23, for the adenosine patients.
Among the exercise patients, 839 (18%) had ST
depression during testing, whereas only 61 (4%) had ST
depression during adenosine infusion. The annualized
mortality in the exercise and adenosine patients with ST
segment depression was (0.8% and 2.6%/year, respec-
tively, P\.0001). In the exercise patients, 424 (9%) had
chest pain with exercise, compared to only 25 (2%)
adenosine patients, with annualized mortality rates of 1.1
and1.9%/yearinthesetwogroups,respectively,P = .26.
Propensity-Based Comparisons
We next used propensity analysis to match exercise
and adenosine patients who did not have TID, LBBB,
paced, aﬁb, or were taking digoxin, or had left
Table 1. Comparison of exercise and adenosine patients
Exercise (N 5 4,557) Adenosine (N 5 1,512) P-values*
Age 59.9 ± 12.4 68.8 ± 12.1 \.0001
Male 2585 (56.7%) 537 (35.5%) \.001
Chest pain symptoms \.001 overall
Asymptomatic 1478 (32.4%) 433 (28.6%) .006
Non-anginal chest pain 1270 (27.9%) 342 (22.6%) \.001
Atypical angina 1245 (27.3%) 466 (30.8%) .009
Typical angina 423 (9.3%) 167 (11.0%) .045
Dyspnea only 140 (3.1%) 104 (6.9%) \.001
CAD risk factors
Diabetes 344 (7.6%) 233 (15.4%) \.001
Hypercholesterolemia 1977 (43.4%) 560 (37.0%) \.001
Smoking 674 (14.8%) 191 (12.6%) .04
Family history 1148 (25.2%) 298 (19.7%) \.001
Hypertension 1786 (39.2%) 843 (55.8%) \.001
Body mass index 26.3 ± 4.5 26.7 ± 5.5 .03
Claudication 7 (0.2%) 4 (0.3%) .48
Pre-test CAD likelihood 33.9 ± 29.1 44.3 ± 30.0 \.0001
Medications while testing
Beta-blockers 263 (5.8%) 165 (10.9%) \.001
Calcium-blockers 376 (8.3%) 188 (12.4%) \.001
Digoxin 191 (4.2%) 115 (7.6%) \.001
Hemodynamics and ECG ﬁndings
Resting heart rate 68.8 ± 12.5 72.1 ± 14.2 \.0001
Resting systolic BP 137.6 ± 21.5 149.8 ± 27.7 \.0001
Resting diastolic BP 84.9 ± 10.6 80.2 ± 12.6 \.0001
Left bundle branch block 39 (0.9%) 63 (4.2%) \.001
Paced rhythm 30 (0.7%) 55 (3.6%) \.001
Left ventricular hypertrophy 390 (8.6%) 214 (14.2%) \.001
Left ventricular enlargement 266 (5.9%) 45 (3.0%) \.001
Arial ﬁbrillation 53 (1.2%) 57 (3.8%) \.001
*All P-values for continuous variables were Wilcoxon rank-sum test, and Pearson v
2 test for categorical variables.
CAD, Coronary artery disease; BP blood pressure.
1002 Rozanski et al Journal of Nuclear Cardiology
Adenosine vs exercise SPECT November/December 2010ventricular enlargement or shortness of breath. Matching
was done on the basis of age (grouped for the purpose of
matching by half-decade), gender, asymptomatic or non-
anginal chest pain symptom, diabetes, hypercholester-
olemia, smoking, family history of CAD, hypertension,
body mass index, inﬂuence of beta-blockers or calcium-
blockers, resting heart rate, resting systolic and diastolic
blood pressure, and left ventricular hypertrophy. The
propensity model is presented in the Appendix. The
propensity scores were matched to an average difference
of 0.05 (median matching precision = 0.03) and the
largest difference was \0.15 between individual aden-
osine and matched exercise patients. The resultant
clinical characteristics of the two propensity-matched
subgroups are listed in Table 2. A small but statistically
signiﬁcant difference persisted in the average diastolic
blood pressure between the two groups, but the groups
were otherwise comparably matched in terms of clinical
presentation, risk factor proﬁles, and Bayesian likeli-
hood of CAD. Yet within these propensity-matched
subgroups, the annualized mortality event rate remained
substantially higher within the adenosine cohort (3.9%
[95% CI: 3.5%-4.3%] vs 1.6% [95% CI: 1.4%-1.9%],
P\.0001). A comparison of adjusted Kaplan–Meier
estimates for mortality in the exercise and adenosine
patients before and after propensity matching indicated
an approximately fourfold higher rate of mortality prior
to propensity-matching (Figure 1A), and twofold higher
rate following propensity matching (Figure 1B).
To assess if these differences varied in younger vs
older patients, we divided our matched patients into
those who were B55, 55-65, and[65 years. Analysis of
the Kaplan–Meir curves revealed that the difference in
mortality rates among the normal SPECT exercise vs
adenosine patients persisted in each age group
(Figure 2).
Among the propensity-matched patients, compari-
son was also made between the adenosine and exercise
groups after dividing the latter group according to
exercise duration (Figure 3). As exercise duration
diminished, mortality rate increased progressively. The
annualized mortality rates for those exercising C9,
Table 2. Comparison of exercise and adenosine patients following propensity matching
Exercise (N 5 1,125) Adenosine (N 5 1,125) P-values**
Age* 66.8 ± 11.0 67.4 ± 12.0 .08
Male* 411 (36.5%) 396 (35.2%) .49
Chest pain symptoms
Asymptomatic* 320 (28.4%) 337 (30.0%) .57
Non-anginal chest pain* 289 (25.7%) 259 (23.0%) .15
Atypical angina 387 (34.4%) 389 (34.6%) .93
Typical angina 129 (11.5%) 140 (12.4%) .46
CAD risk factors
Diabetes* 140 (12.4%) 167 (14.8%) .10
Hypercholesterolemia* 462 (41.1%) 435 (38.7%) .24
Smoking* 150 (13.3%) 150 (13.3%) 1.00
Family history* 227 (20.2%) 231 (20.5%) .83
Hypertension* 618 (54.9%) 619 (55.0%) 1.00
Body mass index* 26.5 ± 5.0 26.9 ± 5.5 .09
Claudication 1 (0.1%) 2 (0.2%) 1.00
Pre-test CAD likelihood 40.4 ± 28.8 41.2 ± 28.3 .55
Medications while testing
Beta-blockers* 118 (10.5%) 116 (10.3%) .89
Calcium-blockers* 129 (11.5%) 129 (11.5%) 1.00
Hemodynamics and ECG ﬁndings
Resting heart rate* 71.9 ± 13.9 71.9 ± 13.9 .92
Resting systolic BP* 146.7 ± 23.1 148.7 ± 27.2 .08
Resting diastolic BP* 81.4 ± 10.4 80.1 ± 12.5 .003
Left ventricular hypertrophy* 144 (12.8%) 159 (14.1%) .35
* Patients were matched on these characteristics (asymptomatic and non-anginal chest pain patients were grouped together for
matching purposes).
** All P-values for continuous variables were Wilcoxon matched-pairs signed-rank test, McNemar, or Exact McNemar test.
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3.4%, respectively (trend P\.0001). The mortality rate
for patients unable to exercise for more than 3 min was
similar to that observed among patients undergoing
adenosine SPECT (P = .65).
We also assessed outcomes among the 349 (8%) of
our exercising patients who underwent a modiﬁed Bruce
protocol compared to the 4,208 (92%) patients who
underwent standard Bruce protocol exercise. The sub-
group undergoing modiﬁed Bruce protocol exercise
were older (66.0 ± 12.1 vs 59.4 ± 12.3 years, P\
.0001), had a lower mean exercise duration (7.0 ± 3.2 vs
7.5 ± 2.7 min, P = .003), and a substantially higher
annualized mortality event rate: 2.4% (1.9%-3.0%) vs
0.9% (0.8%-1.0%), P\.0001. Comparable differences
in event rates persisted for the exercise versus adenosine
patient subgroups that did and did not have resting ECG
abnormalities at rest (P\.003 for both pairwise
comparisons).
We further assessed the comparative event rate in
the propensity-matched groups, after excluding the
patients with the following co-morbidities in addition to
the ones that were excluded before:current smoking,
diabetes, BMI C 30, presence of LVH, or peripheral
vascular disease. Among the 606 exercise patients and
535 adenosine patients without any of these co-mor-
bidities, the annual mortality rate remained signiﬁcantly
greater among the adenosine patients: 3.6% vs 1.5%
(P\.0001).
Comparison of Short-Term Cardiac
Outcomes
Short-term cardiac events occurred among 44 of our
adenosine patients, including 31 (with one censored)
cardiac deaths and 13 non-fatal myocardial infarctions,
as well as among 27 of our exercise patients, including
12 cardiac deaths and 15 non-fatal myocardial infarc-
tions. The annualized cardiac event rate in the adenosine
vs exercise groups was 1.2% vs 0.2% (P\.0001).
Within the propensity-matched cohorts, the annualized
cardiac event rate in the adenosine vs exercise patients
also remained twofold higher: 1.1% vs 0.2%, P\.0001.
DISCUSSION
In this study, we compared the long-term mortality
rate among patients who had a normal stress–rest
SPECT study during exercise study testing vs during
adenosine infusion. Over our mean 10-year follow-up,
adenosine patients had a markedly greater mortality rate
than did exercise patients, but they were older, with
more diabetes, hypertension, atrial ﬁbrillation, and other
clinical factors. Thus, we used propensity analysis to
deﬁne a matched cohort of exercise and adenosine
patients who had very similar clinical proﬁles. Our
propensity-matched adenosine SPECT patients still had
twice the annual mortality of their exercise counterparts.
Diminished sensitivity for ischemic detection by
adenosine SPECT is an unlikely explanation for our
ﬁndings. Early studies found that comparable magni-
tudes of myocardial ischemia were induced when
experimental patients underwent both dipyridamole (the
ﬁrst vasodilator used in clinical practice) and exercise
myocardial perfusion imaging.
12,13 Subsequently,
patients undergoing both adenosine and exercise SPECT
were also found to have similar sensitivity and speci-
ﬁcity for CAD detection.
14,15
Prior follow-up studies have generally depended on
relatively short-term follow (*2-3 years) to examine
the ‘‘warranty period’’ associated with normal stress
SPECT studies. Previously, we noted an annualized
cardiac event rate that was elevated in our adenosine vs
exercise patients,
16 which we and others
17,18 attributed
to greater age and co-morbidity among adenosine
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Figure 1. Comparison of probability of survival from death
(y-axis) during 10-year follow-up from all causes in patients
undergoing exercise vs adenosine SPECT. (A) Comparison of
all exercise and adenosine patients in our study prior to
propensity matching. (B) The comparative survival in exercise
and adenosine patients following propensity-matching based
on age, gender, chest pain symptom, and CAD risk factors.
ACM, All-cause mortality.
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macological myocardial perfusion studies, Navare et al
3
reported an annualized cardiac event of 1.78% for nor-
mal pharmacological studies vs only 0.65% for normal
exercise studies. These investigators also suggested that
the difference in this risk was attributable to differences
in the a priori risk for cardiac risk in the exercise and
pharmacological populations used for their meta-analy-
sis. More recently, the follow-up of a large cohort of
16,854 consecutive patients with a normal stress SPECT
study reported differences in annualized mortality which
was comparable to that observed in our study: an
annualized mortality rate of 0.6% for their exercise
patients vs 4.1% for their patients undergoing
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Figure 2. Comparative survival of the propensity-matched exercise and adenosine patients
following division of these patients by age.
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Figure 3. Comparison of survival in the propensity-matched exercise and adenosine patients, with
the exercise patients divided according to exercise duration. Mortality rate increased progressively
as exercise duration diminished. There was no statistical difference in mortality rate among patients
unable to exercise[3 min and patients undergoing adenosine SPECT (P = .65).
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19 Similarly, signiﬁcant differ-
ences in event rates have also been noted for dobutamine
vs exercise SPECT.
20,21 However, none of these prior
studies used propensity-analysis or other matching
techniques which would have allowed them to compare
patients with similar coronary risk proﬁles during
pharmacological and exercise stress testing.
Physiological Considerations
Various conditions that inhibit exercise are likely to
be preferentially concentrated among patients undergo-
ing pharmacological stress testing. These include
respiratory diseases; musculoskeletal impairment due to
chronic inﬂammatory autoimmune diseases (e.g., rheu-
matoid arthritis) or degenerative musculoskeletal
disorders (e.g., osteoarthritis); impaired gait, balance or
walking ability stemming from cerebrovascular disease,
degenerative disorders of the central nervous system, or
peripheral vascular disease; fatigue or weakness due to a
range of systemic illnesses or increasing frailty; and
poor exercise conditioning, which may increase with age
or obesity. Since we did not catalog such non-cardiac
conditions at the time our patients underwent stress
SPECT imaging, our propensity analyses could not
exclude these potential co-morbidities as the cause for
our ﬁndings. Nevertheless, various ﬁndings suggest
more that unexamined co-morbidity as an explanation
for our ﬁndings, including the strength of our propensity
analyses and our ﬁnding of substantially higher mor-
tality among propensity-matched patients of all age
groups, including patients\55 years in age. Moreover,
we also observed a marked difference in the rate of
cardiac mortality among patients undergoing pharma-
cological vs exercise SPECT, even after excluding
cardiac co-morbidities and risk factors, including
patients with dyspnea, peripheral vascular disease, atrial
ﬁbrillation, LV enlargement, LVH, diabetes, or the
presence of a high BMI.
Of note, the mortality rate in our pharmacological
patients paralleled that of patients manifesting very poor
exercise tolerance. Mortality in our exercise patients
varied inversely with exercise duration. In part, the
increased events among our patients with low exercise
ﬁtness may have been due to decreased sensitivity for
ischemic detection by SPECT among patients failing to
exercise adequately.
22,23 However, poor exercise ﬁtness
and sedentary behavior also constitute increased risk for
mortality due to their association with inﬂammation and
oxidative stress,
24,25 endothelial dysfunction
25; meta-
bolic syndrome and disturbed glucose metabolism,
26
overweight
27; and adverse association with other
cardiac risk factors, such as lower HDL levels
28
and higher blood pressure.
29 Similarly, these same
pathophysiological factors would be expected to con-
tribute to the increased mortality among those
pharmacological patients in our study who did not per-
form exercise SPECT due to poor exercise tolerance.
Limitations
Our study has a number of limitations. Our study is
a retrospective single-center study and patient matching
was accomplished using statistical techniques but not
prospectively selected similar groups. Moreover, as
aforementioned, concomitant non-cardiac diseases
which we did not assess may have contributed to dif-
ferences in prognosis in our study. Similarly, prior
reported studies concerning the prognostic efﬁcacy of
pharmacological SPECT have not stratiﬁed patients
according to co-morbidities or the reasons for perform-
ing pharmacological rather than exercise myocardial
perfusion SPECT. The other clinical information that is
taken from our exercise studies may have slightly
modiﬁed the interpretation of images while this infor-
mation was not available with the interpretation of the
adenosine studies. Finally, a factor that was unantici-
pated at the time of testing is the potential effect of beta-
blockers and calcium channel blockers on reducing the
presence and size of myocardial perfusion abnormalities
on SPECT images. Several reports suggest that this
effect may be substantial.
30,31 However, the frequency
of adenosine patients who were on calcium or beta-
blockers at the time of testing was relatively small in our
population, and the higher mortality rates among aden-
osine vs exercise patients persisted when such patients
were eliminated from our analyses.
Clinical Signiﬁcance
For years, normal stress myocardial perfusion
imaging has been promulgated as providing a ‘‘war-
ranty’’ for low cardiac risk. Subsequently, various
subgroups have been identiﬁed as having increased risk
despite non-ischemic SPECT responses, including
patients with diabetes,
32 atrial ﬁbrillation,
33 and dysp-
nea.
4 However, even though some studies have also
reported relatively increased events in patients under-
going pharmacological stress,
3,16,17,19 by and large,
patients with normal pharmacological stress tests are
considered as having low cardiac risk, and in our Insti-
tution, these patients have manifested the same low
referral rate to cardiac catheterization as do patients with
normal exercise SPECT. Our ﬁndings of a signiﬁcantly
increased mortality risk in propensity-matched adeno-
sine patients, even among younger propensity-matched
subjects, raise an important potential caution to the easy
assignment of normal pharmacological stress patients to
1006 Rozanski et al Journal of Nuclear Cardiology
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gest that patients with normal pharmacological stress
tests are deserving of closer scrutiny over time com-
pared to patients with normal exercise SPECT studies.
Our ﬁndings also indicate the need for further pro-
spective study to identify the underlying reasons for the
increased mortality among non-ischemic patients stud-
ied by pharmacological means. Such study would assess
the role of various inﬂammatory diseases, occult sub-
clinical atherosclerosis, poor physical ﬁtness and
sedentary lifestyle, and other factors in mediating the
differences in outcome among exercise and adenosine
patients. Future outcome studies should collect pro-
spective information as to the reason(s) for performing
pharmacological stress at the time of testing so that
component factors that contribute to higher mortality
among such patients can be better identiﬁed and studied.
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APPENDIX
Logistic regression model used for deriving
propensity score, predicting having the adeno-
sine test, vs having the exercise test
Predictors OR
95%
Conﬁdence
interval P-value
Age group per half
decades
1.20 (1.16–1.25) \.001
Male gender 0.73 (0.62–0.86) \.001
Appendix continued
Predictors OR 95%
Conﬁdence
interval
P-value
BMI (kg/m
2) 1.05 (1.03–1.06) \.001
Asymptomatic or
non-anginal chest
pain
0.81 (0.70–0.95) .008
Diabetes 1.53 (1.20–1.94) \.001
High cholesterol 0.75 (0.64–0.88) \.001
Smoking 1.31 (1.05–1.63) .02
Family history of
CAD
0.90 (0.75–1.09) .29
Beta-blockers 1.64 (1.25–2.16) \.001
Calcium-blockers 0.87 (0.68–1.12) .28
Hypertension 1.46 (1.23–1.73) \.001
Resting heart rate
(beats/min)
1.03 (1.02–1.03) \.001
Systolic blood
pressure
1.03 (1.02–1.03) \.001
Diastolic blood
pressure
0.92 (0.92–0.93) \.001
LVH 1.48 (1.16–1.89) .001
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